Agilyx, a leading global innovation consultancy, is proud to announce its official induction into Club 10, a select group of organisations dedicated to supporting the national blood cancer charity, Cure Leukaemia.
Through this partnership, Agilyx will provide vital funding for the ATICUS Network – a world-first paediatric transplant trials network, ATICUS is dedicated to finding new, less toxic, and more effective treatments for children battling blood cancer.
The partnership is built on a foundation of shared values. Just as Agilyx drives digital and operational innovation for businesses worldwide, Cure Leukaemia is at the forefront of clinical innovation through funding of clinical trials networks.
Harpal Mattu, supported by John Catarinich, Chris Develin and Shelley Zapp, commented: “At Agilyx, we believe in the power of innovation to solve the world’s most complex challenges. Supporting Cure Leukaemia and the ATICUS Network was a natural choice for us. By supporting these pioneering paediatric trials, we aren’t just supporting a charity; we are investing in a future where children can overcome blood cancer with kinder, more effective treatments. Our global team is incredibly motivated to contribute to a cause that has such a profound, life-saving impact on a worldwide scale.”
The Agilyx team is already gearing up for a series of international fundraising challenges. Colleagues across the globe will be participating in fundraising events, including running the the Sydney Marathon, cycling from London to Paris and taking on the Great Birmingham Half Marathon.
Beyond physical challenges, Agilyx is committed to leveraging its professional network to raise awareness among clients and partners, amplifying the reach of Cure Leukaemia’s mission.
Bhupinder Dhillon, Business Development Manager at Cure Leukaemia, added: “We are thrilled to welcome Agilyx to Club 10. Their reputation for excellence across the region and their global reach make them an invaluable partner. The support from Agilyx will enable us to fast-track funding for clinical trials nurses and infrastructure needed to run the ATICUS trials. This isn’t just a corporate donation, it’s a commitment that will change the lives of young patients. Seeing the Agilyx team get so hands-on with events like the London 2 Paris cycle is truly inspiring, and we look forward to achieving great things together.”